When Europe acts as one but isn’t joined up.

For pretty much the whole of the last six months the team at PCL have been trying to make headway with certain issues thrown up by the EU Guidelines on GDP for Medicinal Products for Human Use (5th Nov 2013). On face value it is hugely helpful that there are common...

Preventing Fake Medicines Entering the Supply Chain

In the developing countries, poor healthcare infrastructure and a high demand for medicines has led to a proliferation of criminal gangs specialising in the counterfeiting of drugs. In the UK there have been several incidents of falsified medicines entering the NHS...

The Price of QUALITY

When speaking to one of our wholesaler clients last week, I was reminded of the real cost of conforming to the regulations that govern the pharmaceutical warehousing (and manufacturing) industries in this country. Making time to spend on quality-related tasks can seem...